James Cintolo

James Cintolo

Share this post

James Cintolo
James Cintolo
💣Myocarditis After mRNA COVID-19 Vaccination-NEW STRATIFIED Data From OXFORD STUDY

💣Myocarditis After mRNA COVID-19 Vaccination-NEW STRATIFIED Data From OXFORD STUDY

New info you need to know

Health by James's avatar
Health by James
Dec 28, 2021
∙ Paid

Share this post

James Cintolo
James Cintolo
💣Myocarditis After mRNA COVID-19 Vaccination-NEW STRATIFIED Data From OXFORD STUDY
Share

Recently, Nature Medicine released a self-controlled case series study done by researchers at Oxford in Europe which examined all individuals 16 and older 1-28 days post vaccination and infection for adverse events1. Of strong public interest, was the correlation between mRNA vaccination with either mRNA-1273 (Moderna), ChAdOx1 (AstraZeneca), or BNT162b2 (Pfizer), and the risk of myocarditis. That said, the results from the original study were harrowing (👉🏻click here to read my analysis of the original study👈🏻2).

Now, fast forward to December 25th 2021, the same authors released updated research from the aforesaid study stratifying myocarditis by age, and sex3. In other words, the authors further broke down their data to pinpoint who was at highest risk for myocarditis after mRNA primary series vaccination+booster dose. Needless to say, THE NEW DATA IS SHOCKING. Nonetheless, this article will break down all pertinent information from the new study.

In this publication you will learn 2 things:

  1. Who is at highest risk for myocarditis after mRNA vaccination and booster

  2. What can be done to lessen the risk of myocarditis after vaccination for those at highest risk

Share

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 James Cintolo
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share